🇺🇸 FDA
Pipeline program

ISIS 325568

ISIS 325568-CS1

Phase 1 small_molecule completed

Quick answer

ISIS 325568 for Type 2 Diabetes Mellitus is a Phase 1 program (small_molecule) at IONIS PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
IONIS PHARMACEUTICALS INC
Indication
Type 2 Diabetes Mellitus
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials